# Major Recall Alert: DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL Recalled Due to Presence of Glass Particles
If you or your organization uses DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL, it’s crucial to read this update. Sun Pharmaceutical Industries has announced a voluntary recall of one specific batch of this cancer treatment medication due to the detection of glass particles in some vials. Here’s everything you need to know about this important recall.
## Why This Recall is Important
When it comes to healthcare, safety is paramount. The recall, issued by Sun Pharma, addresses a serious quality control issue involving **glass particles** found in a specific batch of DOXOrubicin Hydrochloride Liposome Injection. If administered intravenously, these glass particles pose significant health risks such as:
- **Local irritation or swelling** at the site of injection.
- **Blockage of blood vessels**, which could lead to life-threatening blood clot events.
Fortunately, to date, no adverse events or injuries have been reported related to this batch. However, these proactive measures highlight Sun Pharma’s commitment to patient safety.
## Details of the Recall
Here are the key details concerning the recall of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL:
- **Brand Name**: Aisling
- **Batch Affected**: Lot # HAG2581B
- **Expiration Date**: 05/31/2027
- **Number of Vials Recalled**: 675 (hospital/user level)
- **Reason for Recall**: Presence of glass particles detected during production.
- **Product Form**: Translucent red liposomal dispersion, packaged in 25 mL glass single-dose vials.
- **Intended Use**: Treatment of Ovarian Cancer, AIDS-Related Kaposi Sarcoma, and Multiple Myeloma.
Sun Pharma has initiated a swift response to this issue by notifying distributors, hospitals, and healthcare providers.
For visual identification of the product, the vial is labeled as **DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL** with the NDC: **72603-200-01**.
For more detailed information, visit the **official FDA recall notice** [here](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sun-pharmaceutical-industries-inc-sun-pharma-initiates-voluntary-us-nationwide-recall-doxorubicin).
## What You Should Do
If you or your institution has purchased this product, the following steps are recommended:
1. **Cease Usage Immediately**: Stop using vials from Lot # HAG2581B and quarantine them.
2. **Contact for Returns**: Distributors, hospitals, or pharmacies should arrange for returns by contacting Sun Pharma’s recall processor:
- **Inmar Inc.**
- Toll-Free: 855-745-9357 (Monday–Friday, 8:30 am–5:00 pm EST)
- Email: [rxrecalls@inmar.com](mailto:rxrecalls@inmar.com)
3. **Physician Notification**: Consumers who may have received this medication should consult their physician or healthcare provider.
4. **Report Adverse Events**: If any complications are experienced, please report them to the FDA’s MedWatch Program online or by mail/fax.
## Stay Safe – Get Instant Recall Alerts
Product recalls like this illustrate the importance of staying informed about potential risks to your health. Don’t miss crucial safety information—download the [MyRecalls App](#) for timely notifications on product recalls, safety alerts, and more.
### Why Choose MyRecalls?
- **Instant Alerts**: Be the first to know about critical recalls.
- **Customizable Notifications**: Get updates based on your purchases and interests.
- **User-Friendly Interface**: Simplify safety compliance and peace of mind.
Your health is too important to leave to chance. Stay informed, stay safe, and stay proactive.
For more information on this recall and updates on recalled products, visit the official FDA website [here](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sun-pharmaceutical-industries-inc-sun-pharma-initiates-voluntary-us-nationwide-recall-doxorubicin).
---
By staying aware and taking appropriate action, you can protect yourself and others during crucial product recalls. Download our free app now to safeguard your health and safety with real-time alerts!
*Image Source: [FDA Recall Notice](https://myrecalls.app/images/consumer_default.png)*